Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

INTRAVENOUS DEXAMETHASONE VERSUS METHYLPREDNISOLONE IN WITH SEVERE ASTHMA EXACERBATION: A RANDOMISED, OPEN-LABEL, SINGLE-CENTRE STUDY

NCT07731217 is registered in ClinicalTrials.gov with Istanbul Medeniyet University as lead sponsor.

NCT NCT07731217
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07731217 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
INTRAVENOUS DEXAMETHASONE VERSUS METHYLPREDNISOLONE IN WITH SEVERE ASTHMA EXACERBATION: A RANDOMISED, OPEN-LABEL, SINGLE-CENTRE STUDY
Lead sponsor
Istanbul Medeniyet University
Phase
Phase 4
Overall status
Completed
Start date
September 1, 2025
Completion date
July 15, 2026
Enrollment
129 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asthma (diagnosis), asthma exacerbations, status asthmaticus